Angiotensin-converting enzyme inhibitors in the therapy of renal diseases

Journal of Veterinary Pharmacology and Therapeutics

Volumn 27, Issue 5, 2004, Pages 265-281

  Lefebvre, H P ^a   Toutain, P L ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANESTHETIC AGENT; BENAZEPRIL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRONE; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOBARBITAL;

CAT; CHRONIC KIDNEY FAILURE; DOG; DRUG EFFECT; DRUG MECHANISM; FOOD DRUG INTERACTION; GLOMERULOSCLEROSIS; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HYPOTENSION; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVIEW; SODIUM RESTRICTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAT DISEASES; CATS; DOG DISEASES; DOGS; DRUG INTERACTIONS; KIDNEY DISEASES;

CANIS FAMILIARIS; FELIDAE; FELIS CATUS; GLOMERULUS;

EID: 8344250161     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00614.x     Document Type: Review

References (151)

1. Alberola, A.M., Salazar, F.J. & Granger, J.P. (1994) Interaction between angiotensin II and nitric oxide in control of renal hemodynamics in conscious dogs. American Journal of Physiology, 267, R1472-R1478.
2. Anderson, S., Meyer, T.W., Rennke, H.G. & Brenner, B.M. (1985) Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. Journal of Clinical Investigation, 76, 612-619.
3. Anderson, W.P., Alcorn, D., Gilchrist, A.I., Whiting, J.M. & Ryan, G.B. (1989) Glomerular actions of ANG II during reduction of renal artery pressure: a morphometric analysis. American Journal of Physiology, 256, F1021-F1026.
4. Atkins, C.E., Brown, W.A., Coats, J.R. et al. (2002) Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation. Journal of the American Veterinary Medical Association, 221, 654-658.
5. Bakris, G.L. & Weir, M.R. (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine. Archives of Internal Medicine, 160, 685-693.
6. Behnia, R., Molteni, A. & Igic, R. (2003) Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Current Pharmaceutical Design, 9, 763-776.
7. Bidani, A.K., Griffin, K.A., Picken, M. & Lansky, D.M. (1993) Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. American Journal of Physiology, 265, F391-F398.
8. Border, W.A. & Noble, N.A. (1998) Interactions of transforming growth factor-β and angiotensin II in renal fibrosis. Hypertension, 31, 181-188.
9. Brands, M.W., Alonso-Garcia, M., Mizelle, H.L., Montani, J.P., Hildebrandt, D.A. & Hall, J.E. (1993) Chronic angiotensin-converting-enzyme inhibition improves cardiac output and fluid balance during heart failure. American Journal of Physiology, 264, R414-R422.
10. Brooks, D.P., DePalma, P.D. & Ruffolo, R.R. (1992) Effect of captopril and the nonpeptide angiotensin II antagonists. SK&F 108566 and EXP3174 on renal function in dogs with a renal artery stenosis. Journal of Pharmacology and Experimental Therapeutics, 263, 422-427.
11. Brown, N.J. & Vaughan, D.E. (1998) Angiotensin-converting enzyme inhibitors. Circulation, 97, 1411-1420.
12. Brown, S.A., Walton, C.L., Crawford, P. & Bakris, G.L. (1993) Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria. Kidney International, 43, 1210-1218.
13. Brown, S.A., Finco, D.R. & Navar, L.G. (1995) Impaired renal autoregulatory ability in dogs with reduced renal mass. Journal of the American Society of Nephrology, 5, 1768-1774.
14. Brown, S.A., Langford, K. & Tarver, S. (1997) Effects of certain vasoactive agents on the long-term pattern of blood pressure, heart rate, and motor activity in cats. American Journal of Veterinary Research, 58, 647-652.
15. Brown, S.A., Brown, C.A. & Hendi, R. (2000) Does systemic hypertension damage the canine kidney? Journal of Veterinary Internal Medicine, 14, 351.
16. Brown, S.A., Brown, C.A., Jacobs, G., Stiles, J., Hendi, R.S. & Wilson, S. (2001) Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency. American Journal of Veterinary Research, 62, 375-383.
17. Brown, S.A., Finco, D.R., Brown, C.A., Crowell, W.A., Alva, R., Ericsson, G.E. & Cooper, T. (2003) Evaluation of the effects of inhibition of angiotensin converting enzyme with enalapril in dogs with induced chronic renal insufiiciency. American Journal of Veterinary Research, 64, 321-327.
18. Buranakarl, C., Mathur, S. & Brown, S.A. (2004) Effects of dietary sodium chloride intake on renal function and blood pressure in cats with normal and reduced renal function. American Journal of Veterinary Research, 65, 620-627.
19. Cheng, H.F., Wang, J.L., Zhang, M.Z., Miyazaki, Y., Ichikawa, I., McKanna, J.A. & Harris, R.C. (1999) Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. Journal of Clinical investigation. 103, 953-961.
20. Chetboul, V., Lefebvre, H.P., Pinhas, C., Clerc, B., Boussouf, M. & Pouchelon, J.L. (2003) Spontaneous feline hypertension: clinical and echocardiographic abnormalities, and survival rate. Journal of Veterinary Internal Medicine, 17, 89-95.
21. Cogan, M.G. (1990) Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension, 15, 451-458.
22. Cortes, P., Riser, B.L., Yee, J. & Narins, R.G. (1999) Mechanical strain of glomerular mesangial cells in the pathogenesis of glomerulosclerosis: clinical implications. Nephrology Dialysis Transplantation, 14, 1351-1354.
23. Cowgill, L. & Kallet, A. (1986) Systemic hypertension. In Current Veterinary Therapy. IX. Ed. Kirk, R. pp. 360-364. WB Saunders, Philadelphia.
24. De Wildt, S.N. & Smith, F.G. (1997) Effects of the angiotensin converting enzyme (ACE) inhibitor, captopril on the cardiovascular, endocrine, and renal responses to furosemide in conscious lambs. Canadian Journal of Physiology and Pharmacology, 75, 263-270.
25. DeForrest, J.M., Waldron, T.L. & Antonaccio, M.J. (1982) Renal response to captopril in conscious dogs pretreated with indomethacin. American Journal of Physiology, 243, F543-F548.
26. Dow, S.W., Fettman, M.J., LeCouteur, R.A. & Hamar, D.W. (1987) Potassium depletion in cats: renal and dietary influences. Journal of the American Veterinary Medical Association, 191, 1569-1575.
27. Elliott, J., Barber, P.J., Syme, H.M., Rawlings, J.M. & Markwell, P.J. (2001) Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. Journal of Small Animal Practice, 42, 122-129.
28. Evans, M.A., Burnett, J.C. & Redfield, M.M. (1995) Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure. Journal of the American College of Cardiology, 25, 1445-1450.
29. Farhi, E.R., Cant, J.R., Paganelli, W.C., Dzau, V.J. & Barger, A.C. (1987) Stimulus-response curve of the renal baroreceptor: effect of converting enzyme inhibition and changes in salt intake. Circulation Research, 61, 670-677.
30. Finco, D.R. & Lloyd, D.E. (2003) Effects of hypertension on renal function and morphology in Page/remnant kidney dogs. Journal of Veterinary Internal Medicine, 17, 406-407.
31. Finco, D.R., Brown, S.A., Brown, C.A., Crowell, W.A., Cooper, T.A. & Barsanti, J.A. (1999) Progression of chronic renal disease in the dog. Journal of Veterinary Internal Medicine, 13, 516-528.
32. Fitzsimons, J.T. & Moore-Gillon, M.J. (1980) Drinking and antidiuresis in response to reductions in venous return in the dog: neural and endocrine mechanisms. Journal of Physiology, 308, 403-416.
33. Galler, M., Backenroth, R., Folkert, V.W. & Schlondorff, D. (1981) Effect of converting enxyme inhibitors on prostaglandin synthesis by isolated glomeruli and aortic strips from rats. Journal of Pharmacology and Experimental Therapeutics, 220, 23-28.
34. Garcia, N.H., Baigorria, S.T. & Juncos, L.I. (2001) Hyperkalemia, renal failure and converting-enzyme inhibition. An overrated connection. Hypertension, 38, 639-644.
35. Grauer, G.F., Greco, D.S., Getzy, D.M., Cowgill, L.D., Vaden, S.L., Chew, D.J., Polzin, D.J. & Barsanti, J.A. (2000) Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. Journal of Veterinary Internal Medicine, 14, 526-533.
36. Grodecki, K.M., Gains, M.J., Baumal, R., Osmond, D.H., Cotter, B., Valli, V.E.O. & Jacobs, R.M. (1997) Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. Journal of Comparative Pathology, 117, 209-225.
37. Gunn-Moore, D. and The BENRIC Study Group (2003a) Influence of proteinuria on survival time in cats with chronic renal insufficiency, Journal of Veterinary Internal Medicine, 17, 405 (abstract).
38. Gunn-Moore, D. and The BENRIC Study Group (2003b) Effects of benazepril in Persian cats with chronic renal insufficiency. Journal of Veterinary Internal Medicine, 17, 435 (abstract).
39. Guron, G., Sundelin, B., Wickman, A. & Friberg, P. (1998) Angiotensin-converting enzyme inhibition in piglets induces persistent renal abnormalities. Clinical and Experimental Pharmacology and Physiology, 25, 88-91.
40. Häggström, J., Hansson, K., Karlberg, B.E., Kvart, C., Madej, A. & Olsson, K. (1996) Effects of long-term treatment with enalapril of hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. American Journal of Veterinary Research, 57, 1645-1652.
41. Hall, J.E. (1986) Regulation of glomerular filtration rate and sodium excretion by angiotensin II. Federation Proceedings, 45, 1431-1437.
42. Hall, J.E., Guyton, A.C., Smith, M.J. & Coleman, T.G. (1979) Chronic blockade of angiotensin II formation during sodium deprivation. American Journal of Physiology, 237, F424-F432.
43. Hamlin, R.L. & Nakayama, T. (1998) Comparison of some pharmacokinetic parameters of 5 angiotensin-converting enzyme inhibitors in normal Beagles. Journal of Veterinary Internal Medicine, 12, 93-95.
44. Harding, P., Glass, W.F. II & Scherer, S.D. (2003) COX-2 inhibition potentiates the antiproteinuric effect of enalapril in uninephrectomized SHR. Prostaglandins, Leukotrienes and Essential Fatty Acids, 68, 17-25.
45. Heller, J., Kramer, H.J. & Horacek, V. (1997) Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog, Kidney and Blood Pressure Research, 20, 391-397.
46. Hemmelder, M.H., De Zeeuw, D., Gansevoort, R.T. & De Jong, P.E. (1996) Blood pressure reduction initiates the antiproteinuric effect of ACE inhibition. Kidney International, 49, 174-180.
47. Henik, R.A., Snyder, P.S. & Volk, L.M. (1997) Treatment of systemic hypertension in cats with amlodipine besylate. Journal of the American Animal Hospital Association, 33, 226-234.
48. Hoskins, J.D., Turnwald, G.H., Kearney, M.T., Gosset, K.A. & Fakier, N. (1991) Quantitative urinalysis in kittens from four to thirty weeks after birth. American Journal of Veterinary Research, 52, 1295-1299.
49. Ingami, T. (1999) Molecular biology and signaling of angiotensin receptors; an overview. Journal of the American Society of Nephrology, 10, S2-S7.
50. Jacob, J., Polzin, D., Osborne, C.A., Neaton, J.D., Lekcharoensuk, C., Allen, T.A., Kirk, C.A. & Swanson, L.L. (2003) Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure. Journal of the American Veterinary Medical Association, 222, 322-329.
51. Jafar, T.H., Schmid, C.H., Landa, M. et al. (2001) Angiotensin-converting enzyme inhibitors and progression of non diabetic renal disease. A meta-analysis of patient-level data. Annals of Internal Medicine, 135, 73-87.
52. Jensen, J., Henik, R.A., Brownfield, M. & Armstrong, J. (1997) Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. American Journal of Veterinary Research, 58, 535-540.
53. Johnson, R.J., Alpers, C.E., Yoshimura, A., Lombardi, D., Pritzl, P., Floege, J. & Schwartz, S.M. (1992) Renal injury from angiotensin II-mediated hypertension. Hypertension, 19, 464-474.
54. Just, A., Kirchheim, H.R. & Ehmke, H. (1998) Buffering of blood pressure variability by the renin-angiotensin system in the dog. Journal of Physiology, 512, 583-593.
55. Kaczmarczyk, G., Vogel, S., Krebs, M., Bünger, H. & Scholz, A. (1996) Vasopressin and renin-angiotensin maintain arterial pressure during PEEP in nonexpanded, conscious dogs. American Journal of Physiology, 271, R1396-R1402.
56. Kamper, A.L. & Nielsen, O.J. (1990) Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy. Scandinavian Journal of Clinical and Laboratory Investigation, 50, 611-618.
57. Kaplan, N.M. (2001) Low-dose combination therapy: the rationalization for an ACE inhibitor and a calcium channel blocker in higher risk patients. American Journal of Hypertension, 14, 8S-11S.
58. Kastner, P.R., Hall, J.E. & Guyton, A.C. (1982) Renal hemodynamic responses to increased renal venous pressure; role of angiotensin II. American Journal of Physiology, 243, F260-F264.
59. Kim, S. & Iwao, H. (2001) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacological Reviews. 52, 11-34.
60. King, J.N., Maurer, M., Morrison, C.A., Mauron, C. & Kaiser, G. (1997) Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog. Xenobiotica, 27, 819-829.
61. King, J.N., Strehlau, G., Wernsing, J. & Brown, S.A. (2002) Effect of renal insufficiency on the pharmacokinetics of benazepril in cats. Journal of Veterinary Pharmacology and Therapeutics, 25, 371-378.
62. Kitagawa, H., Wakamiya, H., Kitoh, K., Kuwahara, Y., Ohba, Y., Isaji, M., Iwasaki, T., Nakano, M. & Sasaki, Y. (1997) Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency. Journal of Veterinary Medical Sciences, 59, 513-520.
63. Kittleson, M.D., Johnson, L.E., Pion, P.D. & Mekhamer, Y.E. (1993) The acute haemodynamic effects of captopril in dogs with heart failure. Journal of Veterinary Pharmacology and Therapeutics, 16, 1-7.
64. Kobayashi, D.L., Peterson, M.E., Graves, T.K., Lesser, M. & Nichols, C.E. (1990) Hypertension in cats with chronic renal failure or hyperthyroidism. Journal of Veterinary Internal Medicine, 4, 58-62.
65. Koch, J., Pedersen, H.D., Jensen, A.L., Flagstad, A., Poulsen, K. & Bie, P. (1994) Short term effects of acute inhibition of the angiotensin-converting enzyme on the renin-angiotensin system and plasma atrial natriuretic peptide in healthy dogs fed a low-sodium diet versus a normal-sodium diet. Journal of Veterinary Medicine A, 41, 121-127.
66. Lane, I.F., Shaw, D.H., Burton, S.A. & Donald, A.W. (2000) Quantitative urinalysis in healthy Beagle puppies from 9 to 27 weeks of age. American Journal of Veterinary Research, 61, 577-581.
67. Laragh, J.H. (1993) Renin profiling for diagnosis, risk assessment, and treatment of hypertension. Kidney International, 44, 1163-1175.
68. Lavoie, J.L. & Sigmund, C.D. (2003) Minireview: Overview of the renin-angiotensin system - an endocrine and paracrine system. Endocrinology, 144, 2179-2183,
69. Lefebvre, H.P., Laroute, V., Concordet, D. & Toutain, P.L. (1999) Effects of renal impairment on the disposition of orally administered enalapril, benazepril, and their active metabolite, Journal of Veterinary Internal Medicine, 13, 21-27.
70. Lewis, E.J., Hunsicker, L.G., Bain, R.P. & Rhode, R.D. (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy, The Collaborative Study Group, New England Journal of Medicine, 329, 1456-1462.
71. Litman, M.P. (1994) Spontaneous systemic hypertension in 24 cats. Journal of Veterinary Internal Medicine, 8, 79-86.
72. Lohmeier, T.E., Cowley, A.W., Trippodo, N.C., Hall, J.E. & Guyton, A.C. (1977) Effects of endogenous angiotensin II on renal sodium excretion and renal hemodynamics. American Journal of Physiology, 233, F388-F399.
73. Lulich, J.P., Osborne, C.A., O'Brien, T.D. & Polzin, D.J. (1992) Feline renal failure: questions, answers, questions. Compendium on Continuing Education for the Practicing Veterinirian, 14, 227-152.
74. MacDonald, J.S., Bagdon, W.J., Peter, C.P., Sina, J.F., Robertson, R.T., Ulm, E.H. & Bockelman, D.L. (1987) Renal effects of enalapril in dogs. Kidney International, 20, S148-S153.
75. Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J.F.E., Motolese, M., Ponticelli, C., Ritz, E., Zucchelli, P. and The angiotensin-converting enzyme inhibition in Progressive Renal Insufficiency Study Group (1996) Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. New England Journal of Medicine, 334, 939-945.
76. Mathur, S., Syme, H., Brown, C.A., Elliott, J., Moore, P.A., Newell, M.A., Munday, J.S., Cartier, L.M., Sheldon, S.E. & Brown, S.A. (2002) Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency. American Journal of Veterinary Research, 63, 833-839.
77. Matsuda, H., Hayashi, K., Arakawa, K. et al. (1999) Zonal heterogeneity in action of angiotensin-converting enzyme inhibitor on renal microcirculation: role of intrarenal bradykinin. Journal of the American Society of Nephrology, 10, 2272-2282.
78. Matsusaka, T., Miyazaki, Y. & Ichikawa, I. (2002) The renin angiotensin system and kidney development. Annual Review of Physiology. 64, 551-561.
79. McCaa, R.E. & Gillepsie, J.B. (1984) Effect of captopril and enalapril on sodium excretion and blood pressure in sodium deficient dogs. Federation Proceedings, 43, 1336-1341.
80. Mezzano, S.A., Ruiz-Ortega, M. & Egido, J. (2001) Angiotensin II and renal fibrosis. Hypertension, 38, 635-638.
81. Michell, A.R., Bodey, A.R. & Gleadhill, A. (1997) Absence of hypertension in dogs with renal insufficiency. Renal Failure, 19, 61-68.
82. Miller, P.L., Rennke, H.G. & Meyer, T.W. (1991) Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. American Journal of Physiology, 261, F459-F465.
83. Miller, R.H., Lehmkuhl, L.B., Smeak, D.D., DiBartola, S.P. & Radin, J. (1999) Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease. American Journal of Veterinary Research, 60, 1516-1525.
84. Mishina, M., Watanabe, T., Fujii, K., Maeda, H., Wakao, Y. & Takahashi, M. (1998) Non-invasive blood pressure measurements in cats: clinical significance of hypertension associated with chronic renal failure. Journal of Veterinary Medical Sciences, 60, 805-808.
85. Mizelle, H.L., Hall, J.E. & Woods, L.L. (1988) Interactions between cingiotensin II and renal nerves during chronic sodium deprivation. American Journal of Physiology, 255, F823-F827.
86. Morisse, B. & Kersten, U. (1994) Vergleichende Untersuchung mit den ACE-Hemmern Quinapril und Captopril zur Behandlung der dekompensierten Herzinsuffizienz des Hundes. Kleintierpraxis, 39, 295-308.
87. Morisse, B. & Kersten, U. (1995) Zur Therapie der Herzinsuffizienz beim Hund mit den ACE-Hemmern Quinapril und Captopril unter besonderer Berücksichtigung der Auswirkung auf die Nierenfunktion. Kleintierpraxis, 40, 817-826.
88. Muirhead, N. (2001) The rationale for early management of chronic renal insufficiency. Nephrology Dialysis Transplantation, 16, 51-56.
89. Mundel, P. & Shankland, S.J. (2002) Podocyte biology and response to injury. Journal of the American Society of Nephrology, 13, 3005-3015.
90. Naitoh, M., Suzuki, H., Arakawa, K., Matsumoto, A., Ichihara, A., Matsuda, H., Kubota, E., Murakami, M., Nakamoto, H. & Saruta, T. (1997) Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension. American Journal of Physiology, 272, H679-H687.
91. Navar, L.G., Rosivall, L., Carmines, P.K. & Oparil, S. (1986) Effects of locally formed angiotensin II on renal hemodynamics. Federation Proceedings, 45, 1448-1453.
92. Nishiyama, S., Kanno, K., Yoneda, H., Yano, K. & Yamaguchi, I. (1992) Effects of the new angiotensin-converting enzyme inhibitor imidapril on renal hemodynamics and function in anesthetized dogs. Arzneimittel-Forschung, 42, 451-456.
93. Noormohamed, F.H., Fuller, G.N. & Lant, A.F. (1989) Effect of salt balance on the renal and hemodynamic actions of benazepril in normal men. Journal of Clinical Pharmacology, 29, 928-937.
94. Okubo, N., Niimura, F., Nishimura, H., Takemoto, F., Fogo, A., Matsusaka, T. & Ichikawa, I. (1997) Angiotensin-independent mechanisms for aldosterone synthesis during chronic extracellular iluid volume depletion. Journal of Clinical Investigation, 99, 855-860.
95. Omoro, S.A., Majid, S.A., El-Dahr, S.S. & Navar, L.G. (1999) Kinin influences of renal regional blood flow responses to angiotensin-converting enzyme inhibition. American Journal of Physiology, 276, F271-F277.
96. Omoro, S.A., Majid, D.S.A., El-Dahr, S.S. & Navar, L.G. (2000) Roles of ANG II and bradykinin in the renal regional blood flow responses to ACE inhibition in sodium-depleted dogs. American Journal of Physiology, 279, F289-F293.
97. Pages, J.P., Casteignau, M., Fabriès, L. & Jacques, D. (2002) Un cas d'insuffisance rénale aiguë parenchymateuse chez le chien associée à la prise d'un inhibiteur de l'enzyme de conversion. Pratique médicale et chirurgicale de l'animal de compagnie, 37, 375-380.
98. Pavenstädt, H. (2000) Roles of the podocyte in glomerular function. American Journal of Physiology, 278, F173-F179.
99. Pedersen, H.D., Koch, J., Jensen, A.L., Poulsen, K. & Flagstad, A. (1994) Some effects of a low-sodium diet high in potassium on the renin-angiotensin system and plasma electrolyte concentrations in normal dogs. Acta Veterinaria Scandinavica, 35, 133-140.
100. Pedersen, K.M., Pedersen, H.D., Häggström, J., Koch, J. & Ersboll, A.K. (2003) Increased mean arterial pressure and aldosterone-to-renin ration in Persian cats with polycystic kidney disease. Journal of Veterinary Internal Medicine, 17, 21-27.
101. Persson, P.B., Ehmke, H., Kögler, U. & Kirchheim, H. (1989) Modulation of natriuresis by sympathetic nerves and angiotensin 11 in conscious dogs. American Journal of Physiology, 256, F485-F489.
102. Piek, C.J. & Meyer, H.P. (1997) Plasma angiotensin II concentrations and the effect of treatment with enalapril in dogs with proteinuria due to renal disease. The Veterinary Quarterly, 19 (Suppl. 1), 18-19.
103. Polzin, D.J., Osborne, C.A., Jacob, F. & Ross, S. (2000) Chronic renal failure. In Textbook of Veterinary Internal Medicine, 5th edn. Eds Ettinger, S.J. & Feldman, E.C. pp. 1634-1 662. WB Saunders Company, Philadelphia.
104. Pouchelon, J.L., King, J. & The BENCH Study Group (2004) Long-term tolerability of benazepril in dogs with congestive heart failure. Journal of Veterinary Cardiology, 6, 7-13.
105. Preston, R.A. (1999) Renoprotective effects of antihypertensive drugs. American Journal of Hypertension, 12, 19S-32S.
106. Reinhart, G.A. & Lohmeier, T.E. (1996) Role of the renin-angiotensin system in mediating the effects of posture on renal function. American Journal of Physiology, 271, R282-R288.
107. Riegger, G.A.J., Elsner, D. & Kromer, E.P. (1989) Circulatory and renal control by prostaglandins and renin in low cardiac output in dogs. American Journal of Physiology, 256, H1079-H1086.
108. Rosivall, L., Rinder, D.F., Champion, J., Khosla, M.C., Navar, L.G. & Oparil, S. (1983) Intrarenal angiotensin I conversion at normal and reduced renal blood flow in the dog. American Journal of Physiology, 245, F408-F415.
109. Rosivall, L., Narkates, AJ., Oparil, S. & Navar, L.G. (1987) De novo intrarenal formation of angiotensin II during control and enhanced renin secretion. American Journal of Physiology, 252, F1118-F1123.
110. Ruggenenti, P., Perna, A., Zoccali, C., Gherardi, G., Benini, R., Testa, A. & Remuzzi, G. (2000) Chronic proteinuric nephropathies: II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Journal of the American Society of Nephrology, 11, 88-96.
111. Ruggenenti, P., Schiepati, A. & Remuzzi, G. (2001) Progression, remission, regression of chronic renal diseases. Lancet, 357, 1601-1608.
112. Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Blanco, J. & Egido, J. (2001) Angiotensin II activates nuclear factor-kB via AT1 and AT2 receptors in the kidney. American Journal of Pathology, 158, 1743-1756.
113. Salvetti, A., Mattel, P. & Sudano, I. (1999) Renal protection and antihypertensive drugs. Current status. Drugs, 57, 665-693.
114. Sanders, N., Hamlin, R., Buffington, T. & Blaisdell, J. (1992) Effects of enalapril on healthy cats. Journal of Veterinary Internal Medicine, 6, 139 (abstract).
115. Schlesinger, O.P. & Rubin, S.I. (1994) Potential adverse effects of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure. Compendium on Continuing Education for the Practicing Veterinarian, 16, 275-283.
116. Schmidt, M., Krieger, J.P., Devissaguet, M. & Imbs, J.L. (1989) Renal effects of perindoprilat, an, angiotensin-converting enzyme inhibitor, in the anesthetized dog. Journal of Cardiovascular Pharmacology, 13, 283-290.
117. Schnackenberg, C.G. & Granger, J.P. (1997) Verapamil abolishes the preglomerular response to ANG II during intrarenal nitric oxide synthesis inhibition. American Journal of Physiology, 272, R1670-R1676.
118. Seymour, A.A., Asaad, M.M., Lanoce, V.M., Lagenbacher, K.M., Fennell, S.A. & Rogers, W.L. (1993) Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure. Journal of Pharmacology and Experimental Therapeutics, 266, 872-883.
119. Shibuya, H., Cassels, M.W., Huang, T.H.M. & Johnson, G.S. (1998) A polymorphic (TG)n microsatellite in an intro of the canine angiotensin I converting enzyme gene. Animal Genetics, 29, 63-72.
120. Siragy, H.M., Howell, N.L., Ragsdale, V. & Carey, R.M. (1995) Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension, 25, 1021-1024.
121. Su, X., Wei, C.C., Machida, N., Bishop, S.P., Hankes, G.H., Dillon, A.R., Oparil, S. & Dell'Italia, L.J. (1999) Differential expression of angiotensin-converting enzyme and chymase in dogs with chronic mitral regurgitation. Journal of Molecular and Cellular Cardiology, 31, 1033-1045.
122. Susick, R.L., Dominick, M.A., Ulloa, H.M. & Pegg, D.G. (1994) Renal morphology and function in dogs after treatment with the angiotensin-converting enzyme inhibitor quinapril. Journal of Cardiovascular Pharmacology, 23, 275-282.
123. Suwelack, B., Kempkes-Koch, M., Kobelt, V., Hillebrand, U., Matzkies, F., Gerhardt, U. & Hohage, H. (2002) Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition. Transplantation Proceedings, 34, 1763-1766.
124. Syme, H.M., Barber, P.J., Markwell, P.J. & Elliott, J. (2002) Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation. Journal of the American Veterinary Medical Association, 220, 1799-1804.
125. Taugner, F., Baatz, G. & Nobiling, R. (1996) The renin-angiotensin system in cats with chronic renal failure. Journal of Comparative Pathology, 115, 239-252.
126. The GISEN Group (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet, 349, 1857-1863.
127. The Improve Study Group (1995) Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the invasive multicenter prospective veterinary evaluation of enalapril study. Journal of Veterinary Internal Medicine, 9, 234-242.
128. Thurman, J.M. & Schrier, R.W. (2003) Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney. American Journal of Medicine, 114, 588-598.
129. Tocco, D.J., DeLuna, F.A., Duncan, A.E.W., Vassil, T.C. & Ulm, E.H. (1982) The physiological disposition of enalapril maleate in laboratory animals. Drug Metabolism and Disposition, 10, 15-19.
130. Toutain, P.L. & Lefebvre, H.P. (2004) Pharmacokinetics and pharmacokinetics/pharmacodynamics relationships for angiotensin converting enzyme (ACE) inhibitors. Journal of Veterinary Pharmacology and Therapeutics (in press).
131. Toutain, P.L., Lefebvre, H.P. & King, J.N. (2000a) Benazeprilat disposition and effect in dogs revisited with a pharmacokinetic/pharmacodynamic modeling approach. Journal of Pharmacology and Experimental Therapeutics, 292, 1087-1093.
132. Toutain, P.L., Lefebvre, H.P. & Laroute, V. (2000b) New insights on effect of kidney insufficiency on disposition of angiotensin-converting enzyme inhibitors: case of enalapril and benazepril in dogs. Journal of Pharmacology and Experimental Therapeutics, 292, 1094-1103.
133. Uechi, M., Imamoto, S. & Ishikawa, Y. (2002) Dose-dependent inhibition of angiotensin converting enzyme by enalapril in cats. Journal of Veterinary Medical Sciences, 64, 385-387.
134. Valli, V.E., Baumal, R., Thorner, P., Jacobs, R., Marrano, P., Davies, C., Quizilbash, B. & Clarke, H. (1991) Dietary modifications reduces splitting of glomerular basement membrane and delays death due to renal failure in X-linked hereditary nephritis. Laboratory Investigation, 65, 67-73.
135. Villarreal, D., Freeman, R.H. & Johnson, R.A. (1992) Captopril enhances renal responsiveness to ANF in dogs with compensated high-output heart failure. American Journal of Physiology, 262, R509-R516.
136. Vogt, L., Navis, G. & de Zeeuw, D. (2002) Renoprotection: a matter of blood pressure reduction or agent-characteristics? Journal of the American Society of Nephrology, 13, S202-S207.
137. Vollmer, R.R., Boccagno, J.A., Harris, D.N. & Murthy, V.S. (1978) Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs. European Journal of Pharmacology, 51, 39-45.
138. Vollmer, R.R., Boccagno, J.A., Steinbacher, T.E., Horovitz, Z.P. & Murthy, V.S. (1981) Antihypertensive activity of captopril (SQ 14.225), an orally active inhibitor of angiotensin converting enzyme inhibitor in conscious two-kidney perinephretic hypertensive dogs. Journal of Pharmacology and Experimental Therapeutics. 216, 225-231.
139. Waldmeier, F. & Schmid, D. (1989) Disposition of [14C]-benazepril hydrochloride in rat, dog and baboon. Absorption, distribution, kinetics, biotransformation and excretion. Arzneimittel-Forschung, 39, 62-67.
140. Williams, G.M., Davis, J.O., Freeman, R.H., DeForrest, J.M., Seymour, A.A. & Rowe, B.P. (1979) Effects of the oral converting enzyme inhibitor SQ 14225 in experimental high output failure. American Journal of Physiology, 236, F541-F545.
141. Witte, S., Goldenthal, E. & King, J.N. (2003) Effects of benazepril.HCl in healthy cats during long-term treatment. Journal of Veterinary Internal Medicine, 17, 436 (abstract).
142. Wolf, G. (1998) Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics. Nephrology Dialysis Transplantation, 13, 1131-1142.
143. Wolf, G. & Neilson, E.G. (1993) Angiotensin II as a renal growth factor. Journal of the American Society of Nephrology, 3, 1531-1540.
144. Wong, P.C. & Zimmerman, B.C. (1980a) Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril. Life Sciences, 27, 1291-1297.
145. Wong, P.C. & Zimmerman, B.C. (1980b) Mechanism of captopril-induced renal vasodilation in anesthetized dogs after nonhypotensive hemorrhage. Journal of Pharmacology and Experimental Therapeutics, 215, 104-109.
146. Wong, P.C., Zimmerman, B.C., Kraft, E., Kounenis, G. & Friedman, P. (1981) Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril. Journal of Pharmacology and Experimental Therapeutics, 219, 646-650.
147. Wynckel, A., Ebikili, B., Melin, J.P., Randoux, C., Lavaud, S. & Chanard, J. (1998) Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors. American Journal of Hypertension, 11, 1080-1086.
148. Yang, H.M. & Lohmeier, T. (1991) Role of angiotensin in ameliorating the renal actions of norepinephrine. American Journal of Physiology, 261, R1497-R1506.
149. Zimmerman, B.C., Goering, J.L. & Raich, P.C. (1988) Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog. American Journal of Physiology, 255, F944-F952.
150. Zimmerman, B.C., Raich, P.C., Vavrek, R.J. & Stewart, J.M. (1990) Bradykinin contribution to renal blood flow effect of angiotensin converting enzyme inhibitor in the conscious sodium-restricted dog. Circulation Research, 66, 242-248.
151. Zucker, I.H., Chen, J.S. & Wang, W. (1991) Renal sympathetic nerve and hemodynamic responses to captopril in conscious dogs: role of prostaglandins. American Journal of Physiology, 260, H260-H266.